Abstract
A series of novel 1,3,4-thiadiazole derivatives possessing benzisoselenazolone scaffold were designed and synthesized, and their antitumor activities against human cervix adenocarcinoma(HeLa), human liver cancer cell(SMMC-7721), human breast cancer cell(MCF-7) and human lung cancer cell(A549) lines were evaluated by CCK-8 assay. The bioassay results demonstrate that most of the tested compounds showed potent antiproliferative effects against various cell lines. Furthermore, compounds 7c, 7e, 7h, 7i and 7k showed significant antiproliferative activities against SMMC-7721 cells, with IC50 values of 2.38, 2.67, 1.35, 2.75 and 2.48 μmol/L, respectively. Compounds 7a, 7e, 7j and 7l exhibited highly effective antitumor activities against MCF-7 cells, with IC50 values of 2.89, 2.95, 1.12 and 2.75 μmol/L, respectively. Compound 7j was found to be the most potent compound against A549 cells, with an IC50 value of 1.25 μmol/L. The pharmacological results suggest that the substituents of benzylthio-moiety at position 2 on 1,3,4-thiadiazole are vital for modulating antitumor activities against various cancer cell lines.
Similar content being viewed by others
References
Mantovani G., Maccio A., Madeddu C., Serpe R., Massa E., Gramignano G., Lusso M. R., Curreli N., Rinaldi A., J. Exp. Ther. Oncol., 2004, 4, 69
Wood S. M., Beckhaml C., Yosioka A., Darban H., Watson R. R., Integr. Med., 1999, 2(2/3), 85
He J., Li D. D., Xiong K., Ge Y. J., Jin H. W., Zhang G. Z., Hong M. S., Tian Y. L., Yu J., Zeng H. H., Bioorg. Med. Chem., 2012, 20, 3816
El-Bayoumy K., Drugs Fut., 1997, 22(5), 539
Grozav A. I., Gaina L., Kuete V., Silaghi-Dumitrescu L., Efferth T., Zaharia V., Molecules, 2013, 18, 4679
Zaharia V., Ignat A., Ngameni B., Kueke V., Moungang M. L., Fokunang C. N., Vasilescu M., Palibroda N., Cristea C., Silaghi-Dumitrescu L., Ngadjui B. T., Med. Chem. Res., 2013, 22, 5670
Terazawa R., Garud D. R., Hamada N., Fujita Y., Itoh T., Nozawa Y., Nakane K., Deguchi T., Koketsu M., Ito M., Bioorg. Med. Chem., 2010, 18, 7001
Wendel A., Tiegs G., Biochem. Pharmacol., 1986, 35(13), 2115
Parnham M. J., Graf E., Biochem. Pharmacol., 1987, 36(19), 3095
Muller A., Cadenas E., Graf P., Sies H., Biochem. Pharmacol., 1984, 33(20), 3235
Sies H., Free. Rad. Biol. Med., 1993, 14, 313
Saluk J., Bijak M., Nowak P., Wachowicz B., Bioorg. Chem., 2013, 50, 26
Parnham M. J., Leyck S., Graf E., Dowling E. J., Blake D. R., Agents Actions, 1991, 32(1/2), 4
Zhou Z. B., Xia X. P., Xu H. B., Zhao C. X., Chen C. Y., Chem. J. Chinese Universities, 1993, 14(2), 220
Reich H. J., Jasperse C. P., J. Am. Chem. Soc., 1987, 109, 5549
Fu J. N., Wang J. Y., Wang L. H., Wang L., Tang W. C., Cai G. X., Liu M., Zeng H. H., J. Chin. Pharma. Sci., 2010, 19, 163
Deng S. J., Kuang B., Zhou X., Yan J., Zhao F., Jia X. Y., Zeng H. H., J. Peking Univ.(Health Sci.), 2003, 35, 108
Tan Q., Li J., Yin H. W., Wang L. H., Tang W. C., Zhao F., Liu X. M., Zeng H. H., Invest. New Drugs, 2010, 28, 205
Hosseinzadeh L., Khorand A., Aliabadi A., Arch. Pharm. Chem. Life Sci., 2013, 346, 812
Zhao H. C., Shi Y. P., Liu Y. M., Li C. W., Xuan L. N., Wang P., Zhang K., Chen B. Q., Bioorg. Med. Chem. Lett., 2013, 23, 6577
Kumar D., Kumar N. M., Chang K. H., Shah K., Eur. J. Med. Chem., 2010, 45, 4664
Hamama W. S., Gouda M. A., Badr M. H., Zoorob H. H., Med. Chem. Res., 2013, 22, 3556
Kumar D., Vaddula B. R., Chang K. H., Shah K., Bioorg. Med. Chem. Lett., 2011, 21, 2320
Khan I., Ali S., Hameed S., Rama N. H., Hussain M. T., Wadood A., Uddin R., Ul-Had Z., Khan A., Ali S., Choudhary M. Z., Eur. J. Med. Chem., 2010, 45, 5200
Cressier D., Prouillac C., Hernandez P., Amourette C., Diserbo M., Lion C., Rima G., Bioorg. Med. Chem., 2009, 17, 5275
Foroumadi A., Firoozpour L., Emami S., Mansouri S., Ebrahimabadi A. H., Asadipour A., Amini M., Saeid-Adeli N., Shafiee A., Arch. Pharm. Res. 2007, 30(2), 138
Moshafi M. H., Sorkhi M., Emami S., Nakhjiri M., Yahya-Meymandi A., Negahbani A. S., Siavoshi F., Omrani M., Alipour E., Vosooghi M., Shafiee A., Foroumadi A., Arch. Pharm. Chem. Life Sci., 2011, 11, 178
Yusuf M., Khan R. A., Ahmed B., Bioorg. Med. Chem., 2008, 16, 8029
Clerici F., Pocar D., J. Med. Chem., 2001, 44, 931
Pattn S. R., Kittur B. S., Sastry B. S., Jadav S. G., Thakur D. K., Madamwar S. A., Shinde H. V., Indian J. Chem., 2011, 50B, 615
Lee J., Lee H. S., Seo H. J., Son E. J., Lee S. H., Jung M. E., Lee M. W., Han H. K., Kim J., Kang J., Lee J., Bioorg. Med. Chem., 2010, 18, 2178
Liu F., Luo X. Q., Song B. A., Bhadury P. S., Yang S., Jin L. H., Xue W., Hu D. Y., Bioorg. Med. Chem., 2008, 16, 3632
Xu W. M., Li S. Z., He M., Yang S., Li X. Y., Li P., Bioorg. Med. Chem. Lett., 2013, 23, 5821
Siddiqui N., Ahuja P., Malik S., Arya S. K., Arch. Pharm. Chem. Life Sci., 2013, 346, 819
Rajak H., Deshmukh R., Aggarwal N., Kashaw S., Kharya M. D., Mishra P., Arch. Pharm. Chem. Life Sci., 2009, 342, 453
Dekhane D. V., Pawar S. S., Gupta S., Shingare M. S., Patil C. R., Thore S. N., Bioorg. Med. Chem. Lett., 2011, 21, 6527
Amir M., Kumar H., Javed S. A., Arch. Pharm. Chem. Life Sci., 2007, 340, 577
Zhao J., Chen B. Q., Shi Y. P., Liu Y. M., Zhao H. C., Cheng J., Chin. Chem. Lett., 2012, 23, 817
Shi Y. P., Chen B. Q., Ma J., Liu Y. M., Li C. W., Acta. Chim. Sinica, 2011, 69, 2561
Clerici F., Pocar D., J. Med. Chem., 2001, 44, 931
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China(No.20971097) and the Tianjin Municipal Natural Science Foundation, China(No.13JCYBJC24500).
Rights and permissions
About this article
Cite this article
Zhao, J., Xuan, L., Zhao, H. et al. Synthesis and antitumor activities of 1,3,4-thiadiazole derivatives possessing benzisoselenazolone scaffold. Chem. Res. Chin. Univ. 30, 764–769 (2014). https://doi.org/10.1007/s40242-014-4080-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-014-4080-4